Palantir Q3 FY12/24 Earnings Review

DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note is intended to be investment advice and nor should it be relied upon to make investment decisions. Cestrian Capital Research, Inc., its employees, agents or affiliates, including the author of this note, or related persons, may have a position in any stocks, security, or financial instrument referenced in this note. Any opinions, analyses, or probabilities expressed in this note are those of the author as of the note's date of publication and are subject to change without notice. Companies referenced in this note or their employees or affiliates may be customers of Cestrian Capital Research, Inc. Cestrian Capital Research, Inc. values both its independence and transparency and does not believe that this presents a material potential conflict of interest or impacts the content of its research or publications.

Still Just A Software Business, Not The Savior Of The Free World

By Alex King, CEO, Cestrian Capital Research, Inc.

Contrary to the occasional protestations of the CEO, or indeed board members alluding to "tendies" for "our retail shareholders", Palantir remains a software company rather than a gift from the Gods Of America to save the free world.

Since the entire Internet has more or less been commandeered to write up Palantir numbers, allow us to provide a very simple take:

The numbers are good, very good; probably unsustainably good - in the end software company cashflow margins usually top out around here (36% on a TTM UFCF basis) if the revenue line is to keep growing.

The stock has been on fire of late and is probably due a pullback.

Here's the headlines.

Financial Summary

Now, for our paying subscribers of all tiers here, we go on to look at financial fundamentals, valuation analysis, our rating and price targets.